Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2040028.014202025280-83Eating speed and the risk of type 2 diabetes: explorations based on real-world evidenceSai Krishna Gudi,,
Annals of Pediatric Endocrinology & Metabolism10.6065/apem.2020err.0012020254289-289Erratum: Eating speed and the risk of type 2 diabetes: explorations based on real-world evidenceSai Krishna Gudi,,
Diabetes Therapy10.1007/s13300-020-00832-y202011S229-32Introduction: Real-World Evidence in Type 2 DiabetesMohamed Hassanein, Aslam Amod, Kamlesh Khunti, Moon-Kyu Lee, Viswanathan Mohan,,
Value in Health10.1016/j.jval.2012.03.0222012154A3RM1 Real-World Evidence on the Effects of Statin-Fibrate Combination Therapy in Type-2 Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial ReduxB.J. Borah, N. Shah, M. Reinalda, V. Montori,
Diabetes10.2337/db18-2382-pub201867Supplement_1The TenYear, Real-World Population-Based Study in Diabetes Nephropathy with Microproteinuria in Type 2 Diabetes Mellitus—Based on the Diabetes Case Management Program 2001, TaiwanMARTIN M.T. FUH, PEI CHIN CHEN,
Diabetes10.2337/db18-884-p201867Supplement_1A Real-World Evidence in Understanding the Barriers and Behaviours of Insulin Therapy among Indian Type 2 Diabetes Mellitus (T2DM) PatientsPRAVEEN RAJ, DILIP PAWAR, SARAH JABEEN, SHIVARAM VS,
Diabetes, Obesity and Metabolism10.1111/dom.1436420212371518-1531Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real‐world evidence from primary careJoanna Z.J. Ling, Olga Montvida, Kamlesh Khunti, Anthony L. Zhang, Charlie C. Xue, Sanjoy K. Paul,,
Cardiovascular Diabetology10.1186/s12933-021-01362-y2021201Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidenceMeir Schechter, Cheli Melzer-Cohen, Aliza Rozenberg, Ilan Yanuv, Gabriel Chodick, Avraham Karasik, Mikhail Kosiborod, Ofri Mosenzon,,
Practical Diabetes10.1002/pdi.2154201835119-22aReal-world evaluation of the DESMOND type 2 diabetes education and self-management programmeSudesna Chatterjee, Melanie J Davies, Bernie Stribling, Azhar Farooqi, Kamlesh Khunti,
Diabetes Technology & Therapeutics10.1089/dia.2019.00522019218415-422Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT)Vijay Viswanathan, K.P. Singh,